The emerging therapy of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide094734.bloguerosa.com/40642539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment